Tyrosine kinase inhibitor with HER2/NEU receptor inhibition propey?
Lapatinib has both the actions and active against breast cancer cells it is an EGFR inhibitor. Ref: KK Sharma 3rd ed. Pg: 870
Imatinib
Nilotinib
Lapatinib
Sunitinib
Chemotherapy